Opus Genetics (IRD) Institutional Ownership $0.97 -0.02 (-2.18%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$0.96 -0.01 (-0.72%) As of 06/13/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Opus Genetics (NASDAQ:IRD)CurrentInstitutional OwnershipPercentage14.97%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$5.96MNumber ofInstitutional Sellers(last 12 months)0 Get IRD Insider Trade Alerts Want to know when executives and insiders are buying or selling Opus Genetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IRD Institutional Buying and Selling by Quarter Opus Genetics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 AWM Investment Company Inc.524,245$515K0.1%N/A1.153% 5/15/2025 Nantahala Capital Management LLC3,157,895$3.10M0.1%N/A6.943% 5/15/2025 Royal Bank of Canada304,123$299K0.0%N/A0.669% 5/14/2025 BIOS Capital Management LP995,249$977K1.2%N/A2.188% 5/14/2025 Comerica Bank30,000$29K0.0%N/A0.066% 5/14/2025 Mink Brook Asset Management LLC810,080$795K0.8%N/A1.781% 5/14/2025 Voss Capital LP150,000$147K0.0%N/A0.330% 5/12/2025 Virtu Financial LLC26,275$26K0.0%N/A0.058% 5/5/2025 Kestra Private Wealth Services LLC48,341$47K0.0%N/A0.106% 5/2/2025 Apollon Wealth Management LLC28,089$28K0.0%N/A0.062% (Data available from 1/1/2016 forward) IRD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IRD shares? During the previous two years, 10 institutional investors and hedge funds held shares of Opus Genetics. The most heavily invested institutionals were Nantahala Capital Management LLC ($3.10M), BIOS Capital Management LP ($977K), Mink Brook Asset Management LLC ($795K), AWM Investment Company Inc. ($515K), Royal Bank of Canada ($299K), Voss Capital LP ($147K), and Kestra Private Wealth Services LLC ($47K).Learn more on IRD's institutional investors. What percentage of Opus Genetics stock is owned by institutional investors? 14.97% of Opus Genetics stock is owned by institutional investors. Learn more on IRD's institutional investor holdings. Which institutional investors have been buying Opus Genetics stock? Of the 10 institutional investors that purchased Opus Genetics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nantahala Capital Management LLC ($3.16M), BIOS Capital Management LP ($995.25K), Mink Brook Asset Management LLC ($810.08K), AWM Investment Company Inc. ($524.25K), Royal Bank of Canada ($304.12K), Voss Capital LP ($150K), and Kestra Private Wealth Services LLC ($48.34K). How much institutional buying is happening at Opus Genetics? Institutional investors have bought a total of 6,074,297 shares in the last 24 months. This purchase volume represents approximately $5.96M in transactions. Related Companies Cartesian Therapeutics Major Shareholders Inozyme Pharma Major Shareholders Lifecore Biomedical Major Shareholders Neurogene Major Shareholders Prothena Major Shareholders Ocugen Major Shareholders Amarin Major Shareholders Aardvark Therapeutics Major Shareholders MediWound Major Shareholders Tevogen Bio Major Shareholders This page (NASDAQ:IRD) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opus Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Opus Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
